Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy

Bibliographic Details
Title: Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy
Authors: Andrew J Colebatch, John F Thompson, Serigne Lo, Ines Pires da Silva, Georgina V Long, Richard A Scolyer, Kazi J Nahar, Tasnia Ahmed, Umaimainthan Palendira, Alexander M Menzies, Jordan W Conway, Matteo S Carlino, Ismael A Vergara, James S Wilmott, Grace Heloise Attrill, Carina N Owen
Source: Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
Publisher Information: BMJ Publishing Group, 2022.
Publication Year: 2022
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2051-1426
Relation: https://jitc.bmj.com/content/10/6/e004771.full; https://doaj.org/toc/2051-1426
DOI: 10.1136/jitc-2022-004771
Access URL: https://doaj.org/article/bc42aa6825a44fdb8db135c1150e97e4
Accession Number: edsdoj.bc42aa6825a44fdb8db135c1150e97e4
Database: Directory of Open Access Journals
More Details
ISSN:20511426
DOI:10.1136/jitc-2022-004771
Published in:Journal for ImmunoTherapy of Cancer
Language:English